Elemental Magazine reports most of the public’s interest has been focused on the progress of the various vaccine candidates, which could provide the ultimate form of protection against the novel coronavirus. However, much less attention has been paid to monoclonal antibodies, which are drugs that contain specialized proteins that are intended to stop SARS-CoV-2 from infecting healthy cells. The report says these drugs do the work of a vaccine, only they do it more quickly and efficiently — if also less durably.
Myron Cohen, MD, the Yeargan-Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology, explained the potential for monoclonal antibodies to be a game-changing treatment.
Read the article here.